Although albumin has been extensively
used in nanomedicine,
it
is still challenging to fluorinate albumin into fluorine-19 magnetic
resonance imaging (19F MRI)-traceable theranostics because
existing strategies lead to severe 19F signal splitting,
line broadening, and low 19F MRI sensitivity. To this end,
34-cysteine-selectively fluorinated bovine serum albumins (BSAs) with
a sharp singlet 19F peak have been developed as 19F MRI-sensitive and self-assembled frameworks for cancer theranostics.
It was found that fluorinated albumin with a non-binding fluorocarbon
and a long linker is crucial for avoiding 19F signal splitting
and line broadening. With the fluorinated BSAs, paclitaxel (PTX) and
IR-780 were self-assembled into stable, monodisperse, and multifunctional
nanoparticles in a framework-promoted self-emulsion way. The high
tumor accumulation, efficient cancer cell uptake, and laser-triggered
PTX sharp release of the BSA nanoparticles enabled 19F
MRI-near infrared fluorescence imaging (NIR FLI)-guided synergistic
chemotherapy (Chemo), photothermal and photodynamic therapy of xenograft
MCF-7 cancer with a high therapeutical index in mice. This study developed
a rational synthesis of 19F MRI-sensitive albumin and a
framework-promoted self-emulsion of multifunctional BSA nanoparticles,
which would promote the development of protein-based high-performance
biomaterials for imaging, diagnosis, therapy, and beyond.